Quick Answer
VACCINEX, INC. reported Total Revenue of $601.0 thousand for fiscal year 2024.
VACCINEX, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $601.0K | +5.4% |
| 2023 | $570.0K | +107.3% |
| 2022 | $275.0K | -69.4% |
| 2021 | $900.0K | +44.0% |
| 2020 | $625.0K | +19.5% |
| 2019 | $523.0K | -27.8% |
| 2018 | $724.0K | +704.4% |
| 2017 | $90.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $52.0K | +160.0% | -77.6% |
| June 30, 2024 | $232.0K | — | +123.1% |
| March 31, 2024 | $104.0K | -81.1% | +420.0% |
| September 30, 2023 | $20.0K | -60.0% | -96.4% |
| March 31, 2023 | $550.0K | — | +1000.0% |
| September 30, 2022 | $50.0K | +0.0% | +0.0% |
| September 30, 2021 | $50.0K | -92.0% | -94.1% |
| March 31, 2021 | $850.0K | — | +36.0% |
- VACCINEX, INC. showed an increase of +5.4% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2024 period, VACCINEX, INC.’s total revenue has grown by 567.8% (from $90.0 thousand to $601.0 thousand).
- The most recent figure is from VACCINEX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: